RegulatoryGuideline · final

MHRA updates London Region I sandbox call with next-stage application details

🇬🇧 MHRA · Wed 18 Nov 2026

The UK regulator has added information on what happens after expressions of interest are screened for its sandbox for AI-enabled medical devices and NHS providers in London.

The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its call for expressions of interest in the London Region I MHRA Regulatory Sandbox. The revision, dated 18 November 2026, adds information on the next stage of the application process, including what happens once expressions of interest have been screened.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official guideline text: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.